Guidelines and Standard Operating Procedures for the Supply Chain Management of Drugs Used in Mass Drug Administration of Neglected Tropical Disease Programs

One of the constraints to effective control of neglected tropical diseases (NTDs) is that the needed medicines are often not available in sufficient quantities at service delivery points at the time of scheduled mass drug administration (MDAs). Supply systems for NTD drugs (NTDDs) differ from those for most other essential medicines in that NTDDs need to be delivered to selected endemic target sites on a defined schedule based on the frequency of the MDA, which could be once or twice a year. Consequently, NTDD supply chain systems need to be well designed and efficiently managed to ensure that health workers and communities have access to NTDDs and supplies, such as registers, medicines for managing adverse drug reactions (ADRs), height measuring poles, etc., at time of MDA. Availability of these items may be influenced by a variety of factors, including availability of the supplies at the central level, poor stock control, provider experience, economic influences, and transport. This guidance and standard operating procedures (SOPs) document will be valuable additional material for anyone who manages NTDDs—from program managers to service providers, community health workers (CHWs), community drug distributors (CDDs), teachers, technical assistance providers, and public- and private-sector partners. This document describes how to properly manage NTDD supplies throughout the supply chain and distribution process. The guidelines and SOPs serve as a reference document that NTD programs can use to review and enhance their own procedures for managing NTDDs and develop or refine their own SOPs to support the proper implementation of the supply chain components of MDA. These guidelines and SOPs are based on the assumption that countries already have the systems, structures, and processes in place to implement MDAs for NTDs.

, , , ,

Keep Maternal, Newborn, and Child Health Medicines Safe: Introducing MNCH commodities into a pharmacovigilance system

As countries aim to achieve the Sustainable Development Goals, there is an emphasis on increasing the availability of medicines. However, poor quality products or dispensing methods may decrease treatment effectiveness or even result in patient death. ADEs negatively affect patient care and increase costs to the system. A functioning PV system monitors these events and triggers actions to minimize their impact. While some disease-specific areas, such as tuberculosis, have made PV a regular tenant of their treatment programs, medicines used for maternal, newborn, and child health (MNCH) are often ignored in reporting. This case study highlights steps taken to ensure the safe use of medicines for mothers, newborns, and children through regular adverse drug event (ADE) reporting as part of the national pharmacovigilance (PV) program in Bangladesh.

, , ,

Storage Improvement of Peripheral Health Units in Four Districts in Sierra Leone

Proper storage conditions and inventory control have a positive effect on medicine quality, data/recording quality, transparency, and the prevention of loss and expiries that lead to wastage. Medicines can lose their potency over time, and the substances that remain as they break down can be harmful. Poor and disorganized storage can lead to deterioration and result in stock-outs, overstocking, and expiries as personnel will not know what medicines are available. The purpose of the improvement is to prevent early degrading of medicines and improve reporting and stock management practices to create visibility and transparency. It will also help in making timely decisions in cases of stock-out or overstocking.

, , ,

SIAPS West Africa Regional Project End of Project Report

Project dates: 2013-2017

,

SIAPS Guinea End of Project Report

Project dates: 2012-2017

,

Strengthening Medicine Registration in Benin: A Detailed Assessment

In November 2016, at the request of USAID/Benin, SIAPS conducted a rapid assessment of the medicines registration system of the Direction de la Pharmacie, du Médicament et des Explorations Diagnostiques (DPMED) in Benin and made recommendations to address the challenges arising from its current information system. The assessment identified opportunities to improve regulatory processes for the efficient and transparent registration of medicines. The purpose of SIAPS’s technical assistance visit in August 2017 was to conduct a situational analysis regarding the findings and recommendations made after SIAPS conducted a rapid assessment in November 2016. The goal was also to develop appropriate recommendations and a plan for the implementation of Pharmadex software and the management system of the medicines registration process at DPMED, Benin.

, , , , , , , , ,

OSPSANTE: Guide de l’Utilisateur

L’objectif de l’outil OSPSANTE est de capturer, de suivre, d’agréger et de diffuser des informations sur les produits de Nutrition et de lutte contre le paludisme, la PF, la SMI et le VIH, pour soutenir la prise de décision basée sur des éléments de preuve au Mali. L’outil OSPSANTE aidera le pays et les organisations internationales, telles que l’USAID, l’ONUSIDA, l’OMS, le Fonds mondial et autres parties prenantes à améliorer les prévisions, la planification de l’approvisionnement et les achats pour permettre la disponibilité continue des produits de Nutrition et de lutte contre le paludisme, de la PF, de la SMI, et du VIH. Le présent guide de l’utilisateur permettra d’utiliser facilement l’outil OSPSANTE. Il fournit des conseils pas à pas pour accéder à l’outil OSPSANTE et générer des rapports.

, , , , ,

Rapport de quantification des produits de la planification familiale pour la période de janvier 2016 à décembre 2020

L’un des piliers de la sécurité des produits de planification familiale (PF) est la disponibilité continue et optimale des produits de PF. Une bonne quantification de ces produits fondée sur des évidences est un maillon essentiel dans le cadre de la sécurité des produits, car elle assure la planification et la mobilisation des ressources nécessaires, fournit des données et informations pour l’achat et la distribution efficace des produits. Une bonne quantification peut également réduire les coûts et le gaspillage, surtout dans un contexte de ressources limitées. Un exercice de quantification pour les produits de la PF a été mené avec l’assistance technique et financière de l’USAID/SIAPS et la participation de tous les principaux intervenants, dans le but de produire des besoins prévisionnels et un plan d’approvisionnement pour la période de 2017 à 2020. Les résultats de cet exercice de quantification seront utilisés dans la planification pour mobiliser et obtenir des ressources financières pour la période de quantification. La prévision des besoins a été estimée pour l’ensemble du pays (secteur public et marketing social) pour chacune des méthodes. Le plan d’approvisionnement a été élaboré pour les deux secteurs.

, , , , , , , , , , ,

Toward Building Resilient Pharmaceutical Systems: SIAPS Final Report

SIAPS final report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs.

, , , , , , ,

Continuous Results Monitoring and Support System

This is the report of the first continuous results monitoring and support system (CRMS) exercise in Bombali District, which was conducted in May 2016. The purpose of the report is to highlight the findings and observations of the CRMS exercise. A total of 104 health facilities (HFs) (one hospital, 18 community health centers (CHCs), 57 community health posts (CHPs), 26 maternal and child health posts (MCHPs), and two clinics) were assessed using a comprehensive checklist based on selected service and system indicators. The CRMS exercise examined different indicators that focused on stock availability; consumption; expiry; number of patients treated; availability and performance of pharmaceutical information tools; storage conditions; staffing; training; and supervision.

, , , ,